SAN DIEGO, June 23, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired NovoCure Limited (NASDAQ: NVCR) securities between January 5, 2023 and June 5, 2023. NovoCure Limited is an oncology company…Read More
NovoCure Limited NVCR Shareholder Notice Robbins LLP Reminds Investors of Class Action Against NovoCure Limited
